Viewing Study NCT06958705


Ignite Creation Date: 2025-12-25 @ 3:29 AM
Ignite Modification Date: 2025-12-26 @ 2:11 AM
Study NCT ID: NCT06958705
Status: RECRUITING
Last Update Posted: 2025-11-25
First Post: 2025-04-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Venetoclax as Consolidation in CLL Patients Treated With BTK Inhibitor Monotherapy
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module